When you join this study, we will confirm that tumor genetic testing was requested by your doctor. You will be asked to fill out questionnaires (once at baseline and once again 6 months after your genetic tumor results have been reviewed). These questionnaires can be filled out remotely (virtually or over the phone) or in person at UNC-Chapel Hill. Tumor genetic testing is used to help guide treatment in patients with cancer. This consists of sending a tissue or fresh blood sample previously collected during a standard of care procedure, to a company to be tested. A "Precision Oncology Navigator" specific to this study will send your samples for genetic testing. The Precision Oncology Navigator can also help you apply for financial assistance for this testing, if needed. After your genetic test results are done, a pharmacist who specializes in interpreting these tests will review and document the results in your electronic medical record. They may also recommend additional testing, and identify possible treatments or clinical trials that may be suitable for you. These recommendations will be added to your medical record for your doctor to review. If your test results show a genetic marker that qualifies you for a clinical trial at UNC Health, the pharmacist will contact the study team for you. If you are eligible, it will be your choice if you would like to join that study.